Rising and falling of traditional Chinese medicine is not conducive to the development of traditional Chinese Medicine

Source: on August 14, 2013, according to the monitoring of tcd.com, since April this year, the prices of TCD have shown signs of stagflation, the prices of wild TCD have been relatively strong, and the prices of artificially planted TCD have continued to decline In addition, the traditional Chinese medicine represented by Radix Pseudostellariae is in a cold situation, and the current price is less than 20% of the peak period In the past six years, there have been two price surges in the prices of Chinese herbal medicines, namely, 2009 and June 2010 to June 2011 After two skyrocketing rises, the price of traditional Chinese medicine finally reached its historical peak in June 2011, an average increase of 200% compared with the beginning of 2007, and the price of some traditional Chinese medicine has risen more than 100 times or even thousands of times Among them, Cordyceps as the representative of traditional Chinese medicine with the concept of health preservation, the prices are more than gold From 2009 to 2011, all kinds of funds have been increasing at the same time In addition, in the field of artificial planting, the phenomenon of horse racing and enclosure is on the rise, and even many local governments regard the cultivation of traditional Chinese medicine as an important local project The craziness of traditional Chinese medicine once made the downstream Chinese patent medicine enterprises complain incessantly In the Chinese patent medicine enterprises with traditional Chinese medicine, especially herbal medicine as the main raw material, it is very difficult to breed exclusive varieties For example, Panax notoginseng is the raw material of several listed pharmaceutical enterprises, such as Yunnan Baiyao, Tianshili, Zhongheng group, Kangyuan pharmaceutical, etc these pharmaceutical enterprises have developed their own exclusive varieties (Tianshili Compound Danshen dropping pill, Zhongheng group Xueshuantong, etc.), but more pharmaceutical enterprises have not used Panax notoginseng to develop heavy-duty products In the face of the step-by-step attack of traditional Chinese medicine, quite a number of traditional Chinese medicine enterprises even directly participate in the cultivation of traditional Chinese medicine Of course, some of them are really for the purpose of stabilizing the source of goods and controlling the cost, while some of them abandon the pharmaceutical business and use their main energy to sell traditional Chinese medicine and transform themselves into "drug traffickers" In fact, this behavior buried a huge hidden danger for the traditional Chinese medicine industry On the one hand, the excessive profits of Chinese herbal medicines give birth to various ways of quick success and instant profits, including large-scale application of pesticides, chemical fertilizers and the use of sulfur and other chemicals to smoke Chinese herbal medicines in the form of powder and ornaments; on the other hand, the behavior causes the price of Chinese herbal medicines out of control, which makes the development law of Chinese patent medicine and Chinese herbal medicine industry out of balance If the price of traditional Chinese medicine rises normally, the middle and downstream enterprises will not be impacted, but most of them have suffered from large-scale irrational speculation, and the price far deviates from its normal value However, after serious overcapacity and the myth of efficacy is broken, the price of traditional Chinese medicine will plummet At present, the disputes in the field of traditional Chinese medicine are far ahead in all sub sectors of the pharmaceutical industry, which is closely related to the imbalance of the value of traditional Chinese medicine In the field of traditional Chinese medicine, there is always a lack of effective supervision In this context, the overall decline in the price of traditional Chinese medicine is actually a shuffling process from the inside out, which is not a bad thing for the traditional Chinese medicine industry Of course, if the regulation continues to be absent, the price of traditional Chinese medicine will usher in another round in the near future